Norges Bank’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $201M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $291M | Buy |
|
|||||
|
2024
Q3 | $260M | Sell |
|
|||||
|
2024
Q2 | $285M | Sell |
|
|||||
|
2024
Q1 | $355M | Buy |
|
|||||
|
2023
Q4 | $300M | Buy |
|
|||||
|
2023
Q3 | $313M | Buy |
|
|||||
|
2023
Q2 | $307M | Buy |
|
|||||
|
2023
Q1 | $259M | Sell |
|
|||||
|
2022
Q4 | $237M | Buy |
|
|||||
|
2022
Q3 | $191M | Buy |
|
|||||
|
2022
Q2 | $209M | Buy |
|
|||||
|
2022
Q1 | $273M | Buy |
|
|||||
|
2021
Q4 | $308M | Buy |
|
|||||
|
2021
Q3 | $270M | Sell |
|
|||||
|
2021
Q2 | $244M | Sell |
|
|||||
|
2021
Q1 | $200M | Sell |
|
|||||
|
2020
Q4 | $211M | Sell |
|
|||||
|
2020
Q3 | $214M | Buy |
|
|||||
|
2020
Q2 | $167M | Buy |
|
|||||
|
2020
Q1 | $111M | Hold |
|
|||||
|
2019
Q4 | $109M | Buy |
|
|||||
|
2019
Q3 | $102M | Buy |
|
|||||
|
2019
Q2 | $89.2M | Buy |
|
|||||
|
2019
Q1 | $74.9M | Buy |
|
|||||
|
2018
Q4 | $65.6M | Buy |
|
|||||
|
2018
Q3 | $77.9M | Buy |
|
|||||
|
2018
Q2 | $54.1M | Hold |
|
|||||
|
2018
Q1 | $48.1M | Sell |
|
|||||
|
2017
Q4 | $59.3M | Buy |
|
|||||
|
2017
Q3 | $53.9M | Sell |
|
|||||
|
2017
Q2 | $61.5M | Buy |
|
|||||
|
2017
Q1 | $45.9M | Buy |
|
|||||
|
2016
Q4 | $45.6M | Buy |
|
|||||
|
2016
Q3 | $38.2M | Sell |
|
|||||
|
2016
Q2 | $51.2M | Buy |
|
|||||
|
2016
Q1 | $41.8M | Buy |
|
|||||
|
2015
Q4 | $35.3M | Hold |
|
|||||
|
2015
Q3 | $31.7M | Sell |
|
|||||
|
2015
Q2 | $35.5M | Buy |
|
|||||
|
2015
Q1 | $35.4M | Sell |
|
|||||
|
2014
Q4 | $38.3M | Buy |
|
|||||
|
2014
Q3 | $26.3M | Sell |
|
|||||
|
2014
Q2 | $40.6M | Buy |
|
|||||
|
2014
Q1 | $21.2M | Hold |
|
|||||
|
2013
Q4 | $23.6M | Hold |
|
|||||
|
2013
Q3 | $19.8M | Buy |
|
|||||
|
2013
Q2 | $12.3M | Buy |
|